Rather than trying to beat Chinese companies, Coreshell attempting an end run, swapping graphite for its specially coated silicon.

Contract Development and Manufacturing Organizations (CDMOs) enhance drug discovery by providing essential services that reduce costs and accelerate production.

Carlyle Group's acquisition of bluebird bio for $3 per share offers a potential but unlikely $600 million sales milestone by 2027. See why BLUE stock is a Hold.

All Blacks coach Scott 'Razor' Robertson has walked back his comments on New Zealand's eligibility rules, instead falling ...

With I-70 running through the city itself, it becomes the local police's job to stop criminal activity that migrates through ...

Sara Imhof, Ph.D., vice president of the focused initiatives team at the North Carolina Biotechnology Center, has been honored by a regional business publication for her inspiring work to lead North ...

For many space enthusiasts and reporters, it’s difficult to reconcile their admiration for Elon Musk’s work with SpaceX with ...

Candidates running for the Elgin City Council on April 1 provide bio information and answer questions related to why they’re ...

TL;DR: Create your own digital autobiography with this one-year subscription to Autobiographer, now just $69 (reg. $199), the ...

Humanetics’ Novel Radioprotective Agent Being Developed with Funding from Department of Defense as Radiation Medical Countermeasure (MCM)Lifecore ...

Following a pre-specified interim analysis, the Data Safety Monitoring Board (DSMB) recommended the DRAGON trial, a pivotal Phase 3 trial in ...

“Original Sins,” “Strike,” “Notes on Surviving the Fire,” and “There Lives a Young Girl in Me Who Will Not Die.” ...